A meta-analysis by Li et al., involving 57 case-control studies, suggested that C677T polymorphisms in the MTHFR gene may contribute to breast cancer development, while the A1298C polymorphism was not associated with disease risk (Li et al., 2014). Here, MTHFR is linked to breast carcinoma.